Neuroscience Research

Neuroscience is the study of the nervous system - one of the major mammalian systems responsible for sustaining life. The central nervous system (CNS) and peripheral nervous system (PNS) work in concert to coordinate basic functions such as moving and breathing, as well as 'higher order' functions including thought, speech and emotion.

Neuroscience Research Products Areas

Products for Neuroscience Research - Page 114

  1. Cat.No. Product Name Information/Activity
  2. BCC6964 NF 279 202983-32-2 NF 279 chemical structure
  3. BCC6725 PPADS tetrasodium salt PPADS tetrasodiuma is a non-selective P2X receptor antagonist. PPADS tetrasodiuma blocks recombinant P2X1, -2, -3, -5 with IC50s ranging from 1 to 2.6 μM. PPADS tetrasodiuma blocks native P2Y2-like (IC50~0.9 mM) and recombinant P2Y4 (IC50~15 mM) receptors. PPADS tetrasodiuma is an inhibitor of the reverse mode of the Na/Ca²⁺exchanger in guinea pig airway smooth muscle. PPADS tetrasodium salt chemical structure
  4. BCC6749 iso-PPADS tetrasodium salt P2X antagonist iso-PPADS tetrasodium salt chemical structure
  5. BCC7015 PPNDS 1021868-77-8 PPNDS chemical structure
  6. BCC7276 Ro 0437626 134362-79-1 Ro 0437626 chemical structure
  7. BCC6157 Ro 51 1050670-85-3 Ro 51 chemical structure
  8. BCC7548 RO-3 1026582-88-6 RO-3 chemical structure
  9. BCC7079 Suramin hexasodium salt Suramin sodium salt (Suramin hexasodium salt) is a reversible and competitive protein-tyrosine phosphatases (PTPases) inhibitor. Suramin sodium salt is a potent inhibitor of sirtuins: SirT1 (IC50=297 nM), SirT2 (IC50=1.15 μM), and SirT5 (IC50=22 μM). Suramin sodium salt is a competitive inhibitor of reverse transcriptase (DNA topoisomerase II: IC50=5 μM). Suramin sodium salt is an antitrypanosomal, anti-neoplastic and anti-angiogenic agent. Suramin hexasodium salt chemical structure
  10. BCC6155 TC-P 262 873398-67-5 TC-P 262 chemical structure
  11. BCC7373 TNP-ATP triethylammonium salt 61368-63-6 TNP-ATP triethylammonium salt chemical structure

Items 1131 to 1140 of 2025 total